CA
19
3
ADM
33
2
ETR
77
-2
RCL
61
4
HBI
61
-4
HBAN
59
3
FDX
36
-3
XRX
55
6
PEP
38
2
D
55
2
INTC
41
8
WM
60
-2
ACN
54
2
ZTS
38
-2
OI
29
4
EQT
57
7
AN
65
2
AMP
63
6
ESS
48
-2
SLB
56
7
CA
19
3
ADM
33
2
ETR
77
-2
RCL
61
4
HBI
61
-4
HBAN
59
3
FDX
36
-3
XRX
55
6
PEP
38
2
D
55
2
INTC
41
8
WM
60
-2
ACN
54
2
ZTS
38
-2
OI
29
4
EQT
57
7
AN
65
2
AMP
63
6
ESS
48
-2
SLB
56
7
Financhill
Back

ProPhase Labs Stock Price Chart

Free Access to "King of the Quants" Stock Rating System

[Claim Your 3 Free Grades Now]
Sell
15

PRPH
ProPhase Labs

Last Price:
$0.58
Seasonality Move:
0.5%

7 Day Trial

ALL ACCESS PASS

$ 7

Access "King of the Quants" Stock Rating System FREE!

[Claim Your 3 Free Grades Now]
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRPH is experiencing slight buying pressure.

ProPhase Labs Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 0.63 Sell
20-day SMA: 0.67 Sell
50-day SMA: 0.77 Sell
200-day SMA: 2.99 Sell
8-day EMA: 0.63 Sell
20-day EMA: 0.68 Sell
50-day EMA: 0.95 Sell
200-day EMA: 2.57 Sell

ProPhase Labs Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 37.39 Sell
Chaikin Money Flow: -42611 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.6 - 0.74) Sell
Bollinger Bands (100): (0.75 - 2.45) Sell

ProPhase Labs Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for ProPhase Labs Stock

Is ProPhase Labs Stock a Buy?

  • ProPhase Labs share price is 0.60 while PRPH 8-day simple moving average is 0.63, which is a Sell signal.
  • The stock price of PRPH is 0.60 while ProPhase Labs 20-day SMA is 0.67, which makes it a Sell.
  • ProPhase Labs 50-day simple moving average is 0.77 while PRPH share price is 0.60, making it a Sell technically.
  • PRPH stock price is 0.60 and ProPhase Labs 200-day simple moving average is 2.99, creating a Sell signal.

PRPH Technical Analysis vs Fundamental Analysis

Sell
15
ProPhase Labs (PRPH) is a Sell

Is ProPhase Labs a Buy or a Sell?

  • ProPhase Labs stock is rated a Sell
    The current ProPhase Labs [PRPH] share price is $0.60. The Score for PRPH is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.

ProPhase Labs Stock Info

Market Cap:
14.2M
Price in USD:
0.60
Share Volume:
181.3K

ProPhase Labs 52-Week Range

52-Week High:
7.48
52-Week Low:
0.56
Sell
15
ProPhase Labs (PRPH) is a Sell

ProPhase Labs Share Price Forecast

  • What is the ProPhase Labs stock price today?
    The ProPhase Labs stock price is 0.60 USD today.
  • Will PRPH stock go up or go down?
    ProPhase Labs> share price is forecast to RISE/FALL based on technical indicators
  • Is ProPhase Labs overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, ProPhase Labs is overvalued.

Is ProPhase Labs Stock a Buy?

  • ProPhase Labs share price is 0.60 while PRPH 8-day exponential moving average is 0.63, which is a Sell signal.
  • The stock price of PRPH is 0.60 while ProPhase Labs 20-day EMA is 0.68, which makes it a Sell.
  • ProPhase Labs 50-day exponential moving average is 0.95 while PRPH share price is 0.60, making it a Sell technically.
  • PRPH stock price is 0.60 and ProPhase Labs 200-day simple moving average is 2.57, creating a Sell signal.

Fundamental Analysis of ProPhase Labs

Is ProPhase Labs a good investment?

  • Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and a decrease next year of $0.00 per share.

Technical Analysis of ProPhase Labs

Should I short ProPhase Labs stock?

* ProPhase Labs stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.